Product Information
METFORMIN HCL 1,000 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0231 per EA under NDC 62135068405. Its NADAC has been published 195 times since Nov 30, 2022.
FDA first approved this application on Jan 24, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Metformin Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1000 mg/1
Manufacturer
Chartwell RX LLCNDC
62135068405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075972FDA Approved
1/24/2002
TE Code
AB
On Market Since
1/24/2002
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 1,000 MG TABLET has been published 195 times since Nov 30, 2022, and over the history we have for it it has declined 15.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0231 per EA |
|---|---|
| All-time high | $0.0277 (Mar 15, 2023) |
| All-time low | $0.0191 (May 22, 2024) |
| 52-week high | $0.0249 |
| 52-week low | $0.0231 |
| Median price | $0.0243 |
| Average price | $0.0243 |
| Largest weekly change | +29.1% (Aug 21, 2024) |
| Weeks tracked | 195 |
| Tracking since | Nov 30, 2022 |
Generic Alternatives
The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 1,000 MG TABLET, manufactured by Chartwell RX LLC, is $0.0231 per EA (NDC 62135068405), effective Aug 19, 2026.
How has the price of METFORMIN HCL 1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 1,000 MG TABLET has declined 15.2%. It has been tracked across 195 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 1,000 MG TABLET?
Since Nov 30, 2022, the NADAC for METFORMIN HCL 1,000 MG TABLET has ranged from a low of $0.0191 (May 22, 2024) to a high of $0.0277 (Mar 15, 2023), with a median of $0.0243 per EA.
Are there cheaper alternatives to METFORMIN HCL 1,000 MG TABLET?
16 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 1,000 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METFORMIN HCL 1,000 MG TABLET?
METFORMIN HCL 1,000 MG TABLET (NDC 62135068405) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.